The profile of Fiasp® is similar to NovoLog® (insulin aspart injection) 100 U/mL but the formulation has been adjusted to increase the speed of initial insulin absorption.1
Fiasp® has a rapid onset of appearance1,2


Fiasp® has a fast onset of appearance1,2
The profile of Fiasp® is similar to NovoLog® (insulin aspart injection) 100 U/mL but the formulation has been adjusted to increase the speed of initial insulin absorption.1

Pharmacokinetic profile: Fiasp® vs NovoLog®


The clinical relevance of PK results is unknown.
PK results from a randomized, single-center, double-blind, 3-period, crossover study in 51 patients with type 1 diabetes.2

When using mealtime insulin, I have seen lower blood sugar spikes when I plan my dosing ahead of my meal but my unpredictable schedule does not always allow for that.
Mike
TYPE 1
Patient is an adult model and results shown are based on data from clinical studies and may not reflect patient experience.
